» Articles » PMID: 37266381

Genomic Landscape and Gene Expression Profiles of Feline Oral Squamous Cell Carcinoma

Overview
Journal Front Vet Sci
Date 2023 Jun 2
PMID 37266381
Authors
Affiliations
Soon will be listed here.
Abstract

Feline oral squamous cell carcinoma (FOSCC) is a cancer of the squamous cell lining in the oral cavity and represents up to 80% of all oral cancers in cats, with a poor prognosis. We have used whole exome sequencing (WES) and RNA sequencing of the tumor to discover somatic mutations and gene expression changes that may be associated with FOSCC occurrence. FOSCC offers a potential comparative model to study human head and neck squamous cell carcinoma (HNSCC) due to its similar spontaneous formation, and morphological and histological features. In this first study using WES to identify somatic mutations in feline cancer, we have identified tumor-associated gene mutations in six cats with FOSCC and found some overlap with identified recurrently mutated genes observed in HNSCC. Four samples each had mutations in , a common mutation in all cancers, but each was unique. Mutations in other cellular growth control genes were also found such as and . Enrichment analysis of FOSCC gene expression profiles suggests a molecular similarity to human OSCC as well, including alterations in epithelial to mesenchymal transition and IL6/JAK/STAT pathways. In this preliminary study, we present exome and transcriptome results that further our understanding of FOSCC.

Citing Articles

Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma.

Zhu Y, Xu W, He Y, Yang W, Song S, Wen C Cell Biol Toxicol. 2025; 41(1):47.

PMID: 39976849 PMC: 11842515. DOI: 10.1007/s10565-024-09949-3.


In vitro expression of genes encoding HIF1α, VEGFA, PGE2 synthases, and PGE2 receptors in feline oral squamous cell carcinoma.

Nasry W, Rodriguez-Lecompte J, Martin C J Vet Diagn Invest. 2025; 37(2):223-233.

PMID: 39930728 PMC: 11811947. DOI: 10.1177/10406387251315677.


Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future.

Aupperle-Lellbach H, Kehl A, de Brot S, van der Weyden L Vet Sci. 2024; 11(5).

PMID: 38787171 PMC: 11126050. DOI: 10.3390/vetsci11050199.


Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X-linked muscular dystrophy in a cat.

Shelton G, Tucciarone F, Guo L, Coghill L, Lyons L J Vet Intern Med. 2024; 38(1):135-144.

PMID: 38180235 PMC: 10800237. DOI: 10.1111/jvim.16971.


Feline precision medicine using whole-exome sequencing identifies a novel frameshift mutation for vitamin D-dependent rickets type 2.

Habacher G, Malik R, Lait P, Coghill L, Middleton R, Warren W J Feline Med Surg. 2023; 25(6):1098612X231165630.

PMID: 37387221 PMC: 10811982. DOI: 10.1177/1098612X231165630.

References
1.
Ling Z, Cheng B, Tao X . Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities. Int J Cancer. 2020; 148(7):1548-1561. DOI: 10.1002/ijc.33352. View

2.
. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

3.
Bergkvist G, Argyle D, Morrison L, MacIntyre N, Hayes A, Yool D . Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC). Vet Comp Oncol. 2011; 9(2):106-17. DOI: 10.1111/j.1476-5829.2010.00239.x. View

4.
Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov J, Tamayo P . The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2016; 1(6):417-425. PMC: 4707969. DOI: 10.1016/j.cels.2015.12.004. View

5.
Bertone E, Snyder L, Moore A . Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. J Vet Intern Med. 2003; 17(4):557-62. View